Serina Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Serina Therapeutics, Inc. (SER) had Common Stock, Capital Shares Reserved for Future Issuance of 8.84 million shares as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-03-25
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 8.84M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 7.20M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 2.09M shares.
- 2023-09-30: Common Stock, Capital Shares Reserved for Future Issuance 8.50M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 8.84M shares 10-K · filed 2026-03-25 |
| 2024-12-31 | 7.20M shares 10-K · filed 2026-03-25 |
| 2023-12-31 | 2.09M shares 10-K · filed 2025-03-24 |
| 2023-09-30 | 8.50M shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 8.50M shares 10-Q · filed 2023-08-14 |
| 2022-12-31 | 8.50M shares 10-K · filed 2023-03-31 |
| 2019-12-31 | 4.00M shares 10-K/A · filed 2020-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |